Faeth Therapeutics Appoints Dr. Stephen Hahn as Chief Medical Executive and Dr. Jayson Dallas as Chief Executive Officer
Position
Chief Executive Officer
Company
Faeth Therapeutics
Description
Faeth Therapeutics strengthens its leadership team with the appointment of Dr. Stephen Hahn, a renowned radiation oncologist and former Chief Medical Executive of MD Anderson Cancer Center, and Dr. Jayson Dallas, an accomplished biotech leader and former CEO of Aimmune Therapeutics, to its Board of Directors
Quick answer
Faeth Therapeutics Appoints Dr. Stephen Hahn as Chief Medical Executive and Dr. Jayson Dallas as Chief Executive Officer (November 22, 2024). Faeth Therapeutics is based in Austin, Texas, United States.
- Who is the new Chief Executive Officer at Faeth Therapeutics?
- Faeth Therapeutics named Jayson Dallas Chief Executive Officer, announced November 22, 2024.
- What did Faeth Therapeutics announce on November 22, 2024?
- Faeth Therapeutics strengthens its leadership team with the appointment of Dr. Stephen Hahn, a renowned radiation oncologist and former Chief Medical Executive of MD Anderson Cancer Center, and Dr. Jayson Dallas, an accomplished biotech leader and former CEO of Aimmune Therapeutics, to its Board of Directors
- What does Faeth Therapeutics do?
- Rather the company is aiming to interrogate how nutrition can become a “fifth pillar” of cancer care through scientific study.
- Where is Faeth Therapeutics based?
- Faeth Therapeutics is based in Austin, Texas, United States.
- Which similar companies made leadership changes around the same time?
- neurocare (November 21, 2024), Georgiamune (November 19, 2024), NRx Pharmaceuticals (November 18, 2024) and Diakonos Oncology (November 18, 2024) also announced leadership changes within 45 days of Faeth Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- neurocare Group AG Appoints Kevin Reeder as Chief Financial Officer (November 21, 2024)
- Georgiamune Inc. Appoints Mark Avagliano as Chief Business Officer (November 19, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer (November 18, 2024)
- Zentalis Pharmaceuticals Appoints New CEO and Chief Medical Officer (November 15, 2024)
- ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer (November 14, 2024)
Who to call at Faeth Therapeutics, and when
A new leader at Faeth Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Faeth Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Faeth Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Faeth Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Faeth Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Faeth Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.